


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
AGEN
Agenus
$2.84
Strengths

Upgraded on attractively valued

Trading below its fair value
AGEN Price Performance
$3.22 (-11.80%)
$3.69 (-23.04%)
$5.07 (-43.98%)
$3.52 (-19.32%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
AGEN Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
AGEN has Extreme risk level
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 13, 2026
Upgrade
Buy
Zacks
RVMD
Revolution Medicines Inc.
96.95
-1.27%
INBX
Inhibrx
76.27
+5.11%
GILD
Gilead Sciences
141.95
+1.72%
EXEL
Exelixis
41.36
-2.18%
What is AGEN current stock price?
What are AGEN stock strengths?
What is AGEN Risk Level?
What is AGEN market cap and volume?
What is AGEN current Stock IQ?
Should I buy AGEN stock right now?
Is AGEN a Strong Buy right now?
What does a 'Strong Buy' rating mean for AGEN?
What does a 'Strong Sell' rating mean for AGEN?
What factors influence AGEN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
AGEN
Agenus
Current Price
$2.84
Linked to AGEN
RVMD
Revolution Medicines Inc.
96.95
-1.27%
INBX
Inhibrx
76.27
+5.11%
GILD
Gilead Sciences
141.95
+1.72%
EXEL
Exelixis
41.36
-2.18%

AGEN Price Performance
$3.22 (-11.80%)
$3.69 (-23.04%)
$5.07 (-43.98%)
$3.52 (-19.32%)
AGEN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
AGEN Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
AGEN has Extreme risk level
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 13, 2026
Upgrade
Buy
Zacks
AGEN Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value
AGEN Latest Analysis
Agenus Inc. (AGEN) Discusses Zydus Collaboration Global Manufacturing Expansion and Patient Access Initiatives Transcript.
Thu Jan 29, 2026
Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock?. Agenus (AGEN) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Tue Jan 13, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AGEN Stock trends
AGEN Stock performance
AGEN Stock analysis
AGEN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.